Bioequivalence Study of Two Olaparib Tablets in Patients With Cancers
Clinical trial NCT05860530 · COMPLETED
Trial details
- NCT number
- NCT05860530
- Sponsor
- Qilu Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-10
- Primary completion
- 2021-09-08
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.